Timothy P. Walbert - 20 May 2025 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
20 May 2025
Transactions value $
$0
Form type
4
Filing time
22 May 2025, 17:01:26 UTC
Previous filing
26 Feb 2025
Next filing
02 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Walbert Timothy P Director C/O BIOMARIN PHARMACEUTICAL INC., 770 LINDARO STREET, SAN RAFAEL /s/ Tae Sang Yoo, Attorney-in-Fact 22 May 2025 0001349376

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $0 +6.65K +212.46% $0.00 9.78K 20 May 2025 Direct F1
holding BMRN Common Stock 416 20 May 2025 Shares held by Prairie Capital Ventures LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units granted on May 20, 2025. Price not applicable.